The RestoreLeak Consortium obtain a dedicated 3-year funding from the European Union through the 2021 call of the ERA-NET NEURON program on “Neurodevelopmental Disorders” .

22 November 2021 This consortium among several institutions aiming at accelerating the development of effective therapies for the ultrarare CLIFAHDD and IHPRF Syndromes, (NALCN/UNC80 gene mutations)- The RestoreLeak consortium, led…

Continue ReadingThe RestoreLeak Consortium obtain a dedicated 3-year funding from the European Union through the 2021 call of the ERA-NET NEURON program on “Neurodevelopmental Disorders” .